143 related articles for article (PubMed ID: 7904943)
1. Effect of dietary protein on the renal response to fenoldopam in diabetic rats.
Wang YX; Brooks DP
Eur J Pharmacol; 1993 Oct; 248(3):217-21. PubMed ID: 7904943
[TBL] [Abstract][Full Text] [Related]
2. Dopamine DA1 receptor agonist, fenoldopam, reverses glycine-induced hyperfiltration in rats.
Wang YX; Gellai M; Brooks DP
Am J Physiol; 1992 Jun; 262(6 Pt 2):F1055-60. PubMed ID: 1352429
[TBL] [Abstract][Full Text] [Related]
3. Effects of dopamine prodrugs and fenoldopam on glomerular hyperfiltration in streptozotocin-induced diabetes in rats.
Barthelmebs M; Vailly B; Grima M; Velly J; Stephan D; Froehly S; Imbs JL
J Cardiovasc Pharmacol; 1991 Aug; 18(2):243-53. PubMed ID: 1717786
[TBL] [Abstract][Full Text] [Related]
4. Ontogeny of renal response to specific dopamine DA1-receptor stimulation in sheep.
Segar JL; Smith FG; Guillery EN; Jose PA; Robillard JE
Am J Physiol; 1992 Oct; 263(4 Pt 2):R868-73. PubMed ID: 1357989
[TBL] [Abstract][Full Text] [Related]
5. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
Chen CJ; Apparsundaram S; Lokhandwala MF
J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
Christie MI; Smith GW
J Pharmacol Exp Ther; 1994 Feb; 268(2):565-70. PubMed ID: 7906731
[TBL] [Abstract][Full Text] [Related]
7. Tubuloglomerular feedback and blood flow autoregulation during DA1-induced renal vasodilation.
Pollock DM; Arendshorst WJ
Am J Physiol; 1990 Mar; 258(3 Pt 2):F627-35. PubMed ID: 1969238
[TBL] [Abstract][Full Text] [Related]
8. Comparison of dopamine and fenoldopam effects on renal blood flow and prostacyclin excretion in normal and essential hypertensive subjects.
Bughi S; Horton R; Antonipillai I; Manoogian C; Ehrlich L; Nadler J
J Clin Endocrinol Metab; 1989 Dec; 69(6):1116-21. PubMed ID: 2573613
[TBL] [Abstract][Full Text] [Related]
9. The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
de Fijter CW; Comans EF; de Vries PM; Oe PL; Roos JC; Smit AJ; Streurman O; Donker AJ
Neth J Med; 1990 Jun; 36(5-6):267-78. PubMed ID: 1975651
[TBL] [Abstract][Full Text] [Related]
10. Evidence from functional and autoradiographic studies for the presence of tubular dopamine-1 receptors and their involvement in the renal effects of fenoldopam.
Hedge SS; Ricci A; Amenta F; Lokhandwala MF
J Pharmacol Exp Ther; 1989 Dec; 251(3):1237-45. PubMed ID: 2574743
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tubuloglomerular feedback by the D1 agonist fenoldopam in chronically salt-loaded rats.
Häberle DA; Königbauer B
J Physiol; 1991 Sep; 441():23-34. PubMed ID: 1687747
[TBL] [Abstract][Full Text] [Related]
12. Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors.
Bakris GL; Lass NA; Glock D
Kidney Int; 1999 Jul; 56(1):206-10. PubMed ID: 10411694
[TBL] [Abstract][Full Text] [Related]
13. Effects of catechol ring fluorination on cardiovascular and renal activities of fenoldopam enantiomers.
Kinter LB; Mann WA; Weinstock J; Ruffolo RR
Chirality; 1994; 6(5):446-55. PubMed ID: 7915128
[TBL] [Abstract][Full Text] [Related]
14. Renal effect of YM435, a new dopamine D1 receptor agonist, in anesthetized dogs.
Yatsu T; Arai Y; Takizawa K; Kasai-Nakagawa C; Takanashi M; Uchida W; Inagaki O; Tanaka A; Asano M; Honda K; Takenaka T
Eur J Pharmacol; 1997 Mar; 322(1):45-53. PubMed ID: 9088869
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology of SK&F R-105058 and R-106114, N-ethyl carbamate ester prodrugs of fenoldopam.
Brooks DP; DePalma PD; Cyronak MJ; Karpinski K; Weinstock J
Pharmacology; 1990; 41(5):299-308. PubMed ID: 1982634
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Na+,K(+)-ATPase in rat renal proximal tubules by dopamine involved DA-1 receptor activation.
Chen C; Lokhandwala MF
Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):289-95. PubMed ID: 8097567
[TBL] [Abstract][Full Text] [Related]
17. The effect of fenoldopam, a dopaminergic agonist, on renal hemodynamics.
Allison NL; Dubb JW; Ziemniak JA; Alexander F; Stote RM
Clin Pharmacol Ther; 1987 Mar; 41(3):282-8. PubMed ID: 2880688
[TBL] [Abstract][Full Text] [Related]
18. Effects of dopamine DA1-receptor blockade and angiotensin converting enzyme inhibition on the renal actions of fenoldopam in the anaesthetized dog.
Clark KL; Hilditch A; Robertson MJ; Drew GM
J Hypertens; 1991 Dec; 9(12):1143-50. PubMed ID: 1685741
[TBL] [Abstract][Full Text] [Related]
19. Effect of dopamine on renal blood flow, prostaglandins, renin and electrolyte excretion in normal and hypertensive humans.
Horton R; Bughi S; Jost-Vu E; Antonipillai I; Nadler J
Am J Hypertens; 1990 Jun; 3(6 Pt 2):108S-111S. PubMed ID: 1974438
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.
Edwards RM
Eur J Pharmacol; 1986 Jul; 126(1-2):167-70. PubMed ID: 2875883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
